Zai Lab
Jueyu Liu is a Clinical Operations Manager at 再鼎医药 since September 2019, responsible for line management of the CRA group and optimizing clinical trial processes. Previously, Jueyu served as Associate Clinical Operations Manager, focusing on operational excellence and the implementation of clinical trial systems. Prior experience includes roles at 阿斯利康 as a Global Study Associate/Global Study Associate Manager, where responsibilities encompassed supporting global clinical trial delivery, ensuring Trial Master Files' accuracy, and leading vendor management. Earlier positions include Medical Assistant Manager at Yangtze River Pharmaceutical Group and Medical Advisor Intern at Pfizer, alongside intern experience as a Clinical Pharmacist at The General Hospital of Shenyang Military Region. Jueyu holds a Master's degree in Pharmacology from the Shanghai Institute of Materia Medica and a Bachelor's degree in Clinical Pharmacy from Shenyang Pharmaceutical University.
This person is not in any offices
Zai Lab
5 followers
Zai Lab Ltd is a biopharmaceutical company. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the fields of oncology, autoimmune and infectious diseases. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include three drug candidates with greater China rights and three drug candidates with global rights. The greater China rights drug candidates include Niraparib (ZL-2306), Omadacycline (ZL-2401) and ZL-2301. The global rights drug candidates include Fugan (ZL-3101), ZL-2302 and ZL-1101.